To explore the potential role of the lncRNA MEG3 in the pathogenesis of PD, in this study, we compared MEG3 plasma expression levels in patients with PD and healthy subjects, and evaluated the relationship with clinical characteristics and disease severity. This evidence concerns the gene MEG3 and Parkinson disease.